18.97 USD
▼-0.09-0.47%
盘后 18.70 -1.42%
2026-09-15
市值
$4.13B
市盈率
—
EPS
-1.57
股息率
—
52 周区间
3.89 – 21.27
成交量
2.74M
Beta
1.70
目标价
27.08
52W 低 3.8952W 高 21.27
价格走势
公司简介
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company’s lead product candidates include RLY-2608, a pan-mutant and isoform-selective phosphoinostide 3 kinase alpha, or PI3Kα, inhibitor that is in clinical development for the treatment of breast cancer, solid tumor, and vascular malformations; and αGal chaperone for Fabry diseases. It also develops R...